过敏性鼻炎中的微生物群-免疫交叉:肺和肠道微生物群机制
Chendong Wang1, Chuntao Zhai1, Shouxi Hu2
1The Second Clinical Medical College of Shanxi University of Chinese Medicine, Taiyuan, Shanxi Province, China.
过敏性鼻炎 (AR) 涉及免疫系统,可能与肠道和肺部细菌有关. 了解这些微生物组的联系可能会导致对AR症状的新疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 过敏性鼻炎 (AR) 是一种常见的免疫疾病,影响上呼吸系统.
- 新出现的证据表明,AR通过肺部和肠道微生物群的改变影响免疫系统.
- 微生物群在AR病变发生中的作用需要进一步的机理研究.
研究的目的:
- 审查将肺和肠道微生物群与过敏性鼻炎联系在一起的机制.
- 讨论针对AR的微生物组的潜在治疗策略.
- 突出了微生物组表征在AR发展中的重要性.
主要方法:
- 对有关过敏性鼻炎和微生物组现有研究的文献综述.
- 分析关于免疫介导疾病中呼吸道和肠道微生物组之间的相互作用的当前研究.
- 综合发现,以确定机制联系和治疗途径.
主要成果:
- 肺部和肠道微生物组在过敏性鼻炎的发病过程中发挥着重要作用.
- 微生物平衡的改变可以间接影响AR的免疫系统.
- 基于微生物组的干预措施显示出作为AR的新型治疗点的前景.
结论:
- 肠道和肺部微生物组是过敏性鼻炎发展和进展的组成部分.
- 针对微生物组为创新的AR疗法提供了一个有希望的前沿.
- 进一步研究呼吸道和肠道微生物组的机械作用对于推进AR治疗至关重要.
更多相关视频
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
相关概念视频
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction
Allergic Reactions
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
